Habituation of the hypothalamic-pituitary-adrenal (HPA) response to chronic intermittent restraint stress (30 min/day for 15 days) and the cross-sensitization to a heterotypic stress [i.p. lipopolysaccharide (LPS)] were investigated in intact male Sprague Dawley rats, and in rats bearing quinolinic acid lesions to the medial anterior bed nuclei of the stria terminalis (BST) or anterior region of the paraventricular nucleus of the thalamus (PVT). In intact animals, a single period of restraint increased plasma corticosterone levels at 30 min and led to an increase in corticotropin-releasing hormone (CRH) mRNA levels in the PVN at 3 h. LPS had a smaller effect on corticosterone and more variable effect on CRH mRNA. Chronic intermittent restraint stress caused a decrease in body weight and increase in adrenal weights, with concomitant increase in basal corticosterone levels. These animals also displayed marked habituation of the corticosterone and CRH mRNA responses to the homotypic stress of restraint, but no loss of the corticosterone response to the heterotypic stress of LPS and a cross-sensitization of the CRH mRNA response. This pattern of stress responses in control and chronically stressed animals was not significantly affected by lesions to the PVT or BST, two areas which have been implicated in the coping response to stress. Thus, these data provide evidence for independent adaptive mechanisms regulating HPA responses to psychological and immune stressors, but suggest that neither the medial anterior BST nor the anterior PVT participate in the mechanisms of habituation or cross-sensitization.
The hypothalamic-pituitary-adrenal (HPA) axis exhibits marked adaptation of responsiveness following exposure to stressful events. For example, exposure to a single stressful episode can lead both to facilitation of the subsequent response to the same (homotypic) stressor, and to habituation after repeated exposures (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Furthermore, repeated exposure to one stressor can lead to an augmented HPA response to a novel (heterotypic) stressor due to the phenomenon of cross-sensitization (2, 8, (16) (17) (18) (19) , although this does not occur for all combinations of stresses (20, 21) . These adaptive changes are important to maintain reactivity and enable selective responding to different stresses.
Although some authors have failed to detect any changes (22) (23) (24) , it is generally accepted that repeated periods of restraint or immobilization stress evoke a marked habituation of the pituitary-adrenocortical response to this psychological stress (1-7, 9, 10, 13, 25) , although the degree of habituation depends upon the duration of restraint, frequency and number of applications, and the timing of the blood sample. Furthermore, changes in the expression of corticotropin-releasing hormone (CRH) and vasopressin mRNAs in the hypothalamic paraventricular nucleus (PVN) accompany acute exposure to restraint (26) (27) (28) , and recent studies have shown that the increase in CRH mRNA is lost following repeated exposure to restraint (7, 29) . However, it seems unlikely that changes of the peptide content in the final common neuroendocrine neurone would be the sole mechanism underlying stress-specific habituation and cross-sensitization, and other components of the stress pathway must be involved in these phenomena.
Several studies have sought to determine the neural sites at which habituation and cross-sensitization occur through examination of the expression of immediate-early genes. These studies have shown that habituation to restraint stress is correlated with decreased c-fos mRNA or Fos protein expression throughout the neuroaxis (4) , particularly in the PVN (5, 9, (30) (31) (32) (33) , the ventrolateral septum and medial and central amygdaloid nuclei (5, 9, 30) , and midbrain raphe, locus coeruleus and central grey (5, 30, 31) . Repeated restraint also leads to cross-sensitization of Fos expression in the central amygdala induced by a heterotypic stressor (social defeat) (21) , and the regional expression of c-fos mRNA can be evoked by exposure to a novel stress (swim) in restraint-adapted animals (4) . However, this habituation to the homotypic stressor and sensitization to a heterotypic stressor does not occur in all stress paradigms, and may depend upon whether the stressors employ common neural circuits. Stressor-specific cross-sensitization and habituation are most likely to occur when the stimuli employed operate through distinct neural pathways. Recent evidence of the patterns of Fos expression has shown that psychological stresses, such as restraint/immobilization or exposure to an open field arena, act through pathways that are distinct from pathways mediating responses to visceral stressors, such as ether or i.p. injection of lipopolysaccharide (LPS) (34, 35) . Studies of Fos expression have revealed distinct forebrain regions which are activated by these two classes of stimuli, and this is most obviously seen in the amygdala where LPS and restraint, respectively, and exclusively activate the central and medial subnuclei.
Two other areas of interest, in respect of adaptive responses to stress, are the bed nuclei of the stria terminalis (BST) and the paraventricular nucleus of the thalamus (PVT). The BST is an important area for gating amygdaloid inputs to the PVN (36, 37) , and has been considered to be part of a stress coping area (38, 39) . Stimulation of the BST evokes activation of the HPA axis (40) and stimulates behavioural patterns of locomotor and exploratory behaviour similar to those evoked by a period of restraint (41) . Lesions of the BST disrupt HPA responses involving medial amygdala inputs without affecting ether-induced responses (42) , consistent with the fact that ether stress falls into the category of visceral stresses (which includes LPS) that does not involve the medial amygdala (34, 35) . BST lesions also increase reactivity to a conditioned psychological stimulus (noise previously paired with immobilization) as well as the severity of gastric pathology induced by restraint (38) .
While the BST appears to show preferential involvement in responses to psychological stressors, the PVT is one area that is activated by a wide range of stress paradigms, including restraint (19, 43, 44) , the novelty of an open field arena (35) , ether vapour (35) , footshock (45) and LPS (46, 47) . This nucleus is a relay for projections to the prefrontal cortex, nucleus accumbens and amygdala which are involved in the response to stress (45) , and glutamatergic neurones in the PVT may be involved in behavioural sensitization induced by psychostimulant drugs (48) . Interestingly, CRH pathways originating from the lateral BST and central amygdala appear to converge on the PVT (49) and may participate in signalling within this stress circuitry. In this respect, the changes in the expression of central CRH following single or repeated stress may contribute to adaptation of afferent signals to this nucleus.
It has been suggested that plasticity within the PVT may, in part, underlie some of the adaptive responses during chronic stress. Chronic cold stress is a powerful stimulus which sensitizes the response to an acute restraint (heterotypic stress) (18) , and it has been shown that restraint-induced Fos expression is increased in the PVT in chronically cold stressed animals (19) . Although this enhanced neuronal response was suggested to underlie the cross-sensitization, it is equally possible that the enhanced PVT activation was part of the mechanism of habituation to the chronic cold stressor. This possibility is supported by the fact that stress-induced HPA responses are enhanced by PVT lesions but only in the chronically stressed animals (18) . Furthermore, Bhatnagar et al. (50) suggested that lesions of the PVT blocked the habituation of the HPA response to restraint stress.
The aim of the present study was to examine the effect of repeated exposure to a psychological stress (chronic intermittent restraint) on the HPA response to the homotypic stress (restraint) and the response to a heterotypic physical stress (i.p. LPS), and the effect that neurochemical lesions of either the PVT or BST had on the processes of habituation or cross-sensitization.
Materials and methods

Animals and surgical procedures
Male Sprague-Dawley rats (225-300 g), purchased from Bantin and Kingman (Hull, UK), were ear marked for identification and housed six per cage under standard conditions with a 14 : 10 h light/dark illumination cycle (lights on 05.00 h). Rats were randomly assigned to three surgical treatment groups: BST, PVT or sham lesions. Lesions were made in the BST and PVT nuclei using a fresh solution of quinolinic acid [Sigma Q1375 (Sigma, St Louis, MO, USA); 25 mg in 1 ml 1 M NaOH, neutralized with 2 M HCl, diluted to a volume of 10 ml with phosphate-buffered saline (PBS) to pH 7.4]. Animals were anaesthetized using Hypnorm (0.07 ml per 100 g body weight i.m.; Janssen Pharmaceuticals Ltd, Oxford, UK) and diazepam (0.07 ml per 100 g body weight i.p.; Phoenix Pharmaceuticals Ltd, Gloucester, UK) and placed in a stereotaxic frame with the incisor bar set at 3.0 mm below interaural line. The quinolinic acid was injected either bilaterally centred on the medial anterior subdivision of the BST or as a single midline injection centred in the anterior region of the PVT, using a glass cannula introduced through a guide cannula arrangement (51) . The glass cannula (<15 mm diameter) was cemented to a 30-gauge stainless steel tube attached to a length of PE 10 polyethylene tubing, connected to a 10-ml glass syringe, and calibrated to deliver 60 nl solution per mm length of tubing. Using the stereotaxic manipulator a 23-gauge guide cannula was positioned to introduce the glass cannula into the brain according to the following coordinates: BST x0.26 mm posterior to bregma; 1.2 mm from the midline; 6.3 mm ventral to the dura; PVT x1.8 mm posterior to bregma; 5.3 mm ventral to the dura (52) . Four hundred and eighty nl either quinolinic acid or PBS (sham lesions) was injected over 3 min and the cannula left in place for a further 3 min to prevent vertical spread of the excitotoxin. Half the sham lesioned animals were injected with PBS into the BST and the other half into the PVT. Postoperatively, rats were left to recover for 15 days prior to the onset of the stress protocols. Procedures were performed in accordance with the UK Animals (Scientific Procedures) Act.
Stress and blood sampling protocols
All animals were weighed at the beginning and end of the stress protocol. The animals from each of the three surgical treatment conditions were randomly assigned to two stress conditions: chronic intermittent restraint stress or nonstressed controls. Chronic intermittent restraint stress involved placing the rats in clear Perspex tubes (internal diameter 60 mm) for 30 min daily for 14 days. This procedure was performed between 08.00 h and 12.00 h each day. Non-stressed controls were left undisturbed in their home cages in a different room. On day 10 of the stress protocol, a single blood sample was collected from the tail vein of each animal either at 08.00 h (prior to the daily restraint) or at 18.00 h to determine the effects of chronic stress on basal plasma corticosterone levels during the early and late light phase. On day 15, animals in each of the two chronic stress conditions were assigned to a further three experimental conditions: no stress exposure (control), 30 min of restraint stress (restraint) or an i.p. injection of lipopolysaccharide (LPS, Escherischia coli, Sigma 026:B6, 200 mg in 0.2 ml). Tail blood samples were collected after 30 min of restraint stress or 30 min following LPS injection to determine the corticosterone stress responses in the different treatment conditions. Blood samples were collected in heparinized Eppendorf tubes, centrifuged at 3000 r.p.m. for 10-15 min, and the plasma frozen at x20 uC until assayed. All animals were sacrificed 3 h following stress exposure and tissues collected for analysis. Brains were removed and frozen on dry ice, and then stored at x80 uC until sectioned for in situ hybridization and histological analyses. Adrenals, thymus, and spleens were removed and weighed, and results expressed as mg per 100 g of body weight.
Thus, within each of the three lesion groups, there were six treatment groups: animals undergoing no chronic stress (control) exposed to either no acute stress (control/control; CC); acute restraint stress (control/restraint; CR); or acute LPS injection (control/LPS; CLPS), and animals undergoing chronic intermittent restraint before exposure to either no acute stress (restraint/ control; RC); acute restraint stress (restraint/restraint; RR); or acute LPS injection (restraint/LPS; RLPS). There were 8-13 animals in each group.
Corticosterone radioimmunoassay
Total plasma corticosterone concentrations were measured directly in heparinized plasma using a citrate buffer at pH 3.0 to denature the binding globulin (1 ml plasma fraction diluted to 100 ml buffer), antiserum kindly supplied by Professor G. Makara (Institute of Experimental Medicine, Budapest) and [ 125 I]-corticosterone (ICN Biomedicals, Irvine, CA, USA) with a specific activity of 2-3 mCi/mg. Free and antibound steroid were separated by centrifugation with a dextran-coated charcoal solution and the free portion in the charcoal pellet counted in a gamma counter. All samples were run in a single assay: the limit of detection was less than 5 ng/ml and intra-assay variation was less than 8%. Values are expressed as ng/ml plasma.
Histological analysis
To assess the lesions, brains were sectioned in the coronal plane through the BST or PVT at 30 mm thickness and mounted on gelatin-coated slides. The sections were left to dry at ambient temperature until stained. In order to determine the extent of the lesions, sections were stained using cresyl violet and analysed using a Seescan (Sonata II, Cambridge, UK) image analysis system. Damage due to the quinolinic acid was quantified by determining the density of stained nuclei in a fixed area of the regions of interest. This density was expressed as the proportion of a standard template which was occupied by stained nuclei. This measure of cellularity was calculated for the two areas in the sham control group and compared to values obtained from the lesioned animals. Lesioned animals that had values that fell within 2 SD of the mean for sham controls were rejected from the study as not being significantly different from controls.
In situ hybridization histochemistry
Coronal cryostat sections through the centre of the hypothalamic PVN were collected at 12 mm and mounted on gelatin-coated slides (two sections per slide), dried, and stored at x80 uC until analysed. In situ hybridization was performed as previously described (27, 28) . For CRH mRNA determination, the probe used was a 48 mer oligonucleotide probe complimentary to exonic mRNA sequences coding for CRH (CAG TTT CCT GTT GCT GTG AGC TTG CTG AGC TAA CTG CTC TGC CCT GGC) and, for vasopressin, a probe complimentary to exonic mRNA sequences coding for the last 16 amino acids of pro-vasopressin was used (GTA GAC CCG GGG CTT GGC AGA ATC CAC GGA CTC TTG TGT CCC AGC CAG) (53) (54) (55) 
Statistical analysis
All values are expressed as meantSEM. All data were analysed using the Statistical Package for Social Sciences, version 9.0 (SPSS Inc., Chicago, IL, USA) analysis of variance (ANOVA) (P<0.05) and, when appropriate, patterns of mean differences were determined using Newman-Keuls multiple comparisons or Dunnett's contrasts (a=0.05). Data from PVT and BST sham lesioned animals were pooled for statistical analysis of HPA activity.
Results
Histological analysis
By comparison with sections obtained from sham-lesioned controls, quinolinic acid caused a reduction in the cellularity in the BST and PVT at the time of sacrifice 4 weeks postoperatively (Fig. 1) . Analysis of the lesion sites resulted in the rejection of two animals out of 72 with PVT lesions and 16 animals out of 72 with BST lesions, on the basis that the region of reduced cell density did not fully encompass the medial anterior BST or anterior PVT.
Organ and body weights
Chronic intermittent restraint stress over 15 days caused a significant suppression of body weight gain [F(1,168)=12.47, P<0.001] (Fig. 2) . Animals exposed to chronic stress in all surgical treatment conditions demonstrated significantly lower weight gain than respective nonstressed controls. Adrenal wet weights relative to bodyweight were found to increase overall with chronic stress exposure [F(1,170)=6.68, P=0.011] and thymus weighs tended to decrease following chronic stress exposure, although this effect only approached statistical significance [F(1,170)=3.42, P=0.066]. Spleen weights did not vary significantly with either the surgical or chronic stress treatments (P>0.05). These data agree with the literature concerning chronic stress effects on body and adrenal weights (6) and further confirm the physiological efficacy of the chronic intermittent restraint stress.
Diurnal corticosterone secretion
Overall, all surgical treatment groups exhibited elevated plasma corticosterone levels at 18.00 h relative to 08.00 h (Fig. 3) Chronic intermittent restraint stress caused a significant increase in the basal corticosterone levels at both times in the diurnal cycle in sham-lesioned animals [F(1,48)=6.91, P=0.012]. However, in BST lesioned animals, there was a trend for chronic restraint stress to elevate corticosterone levels specifically at the nadir of the diurnal cycle, an effect which, although failing to reach statistical significance [StressrTime, F(1,54)=2.65, P=0.110], caused a marked attenuation of the diurnal difference in corticosterone levels (diurnal difference 18.00 h/08.00 h: sham control, 375%; sham restrained, 405%; BST lesion control, 535%; BST lesion restrained, 188%). In control PVT lesioned animals, Dunnett's post-hoc contrasts revealed that the corticosterone levels at 18.00 h were significantly greater compared with sham control levels at the same time (P<0.01), and levels at both times of the day did not differ from those measured either in repeatedly restrained sham or repeatedly restrained PVT lesioned animals. This suggests that the PVT lesions increased basal corticosterone levels, but occluded any further increase in response to the chronic intermittent restraint.
HPA responses to acute stressors
ANOVA revealed that corticosterone responses to acute restraint stress and LPS on day 15 varied significantly according to a three way interaction [LesionrChronic StressrAcute Stress, F(4,174)=5.64, P<0.005] (Fig. 4A) . All lesion treatment groups that were not previously exposed to restraint stress exhibited equivalent responses to the acute exposure to restraint (CR) and to LPS injection (CLPS), although the corticosterone responses to LPS were much smaller than those to restraint. Similar to the 08.00 h samples obtained on day 10 of the stress protocol (Fig. 3) , chronic intermittent restraint stress increased basal corticosterone levels (CC versus RC). The chronic restraint stress did not alter corticosterone responses to the heterotypic stress of LPS (RLPS) in any of the lesion treatment conditions, either relative to each other or relative to control animals administered LPS (i.e. CLPS). However, repeated restraint stress reduced the corticosterone responses to acute re-exposure to restraint stress (i.e. produced habituation to the homotypic stressor) (RR/CR values: sham-lesioned, 64%; BST-lesioned, 71%; PVT-lesioned, 72%). This decreased response was significant for sham-lesioned animals, but failed to reach significance in the two lesioned groups due to a much greater variance of the data. Analysis of PVN CRH mRNA expression revealed a significant interaction for Chronic StressrAcute Stress [F(2,137)=3.12, P<0.05] (Fig. 4B) . CRH mRNA levels increased in sham control animals exposed to acute restraint stress, while this effect was more variable in response to LPS. However, following chronic repeated restraint, no increase in CRH mRNA expression was seen in animals re-exposed to acute restraint stress compared to controls (homotypic habituation), but a greater and less variable increase in CRH mRNA expression was observed in response to LPS (cross-sensitization). While, overall, this pattern of CRH mRNA responses did not differ between lesion treatment groups (P>0.05), CRH mRNA levels in the BST lesioned animals were unexpectedly elevated in the basal condition (CC group), thereby precluding our ability to detect any effects due to either of the acute stressors. However, CRH mRNA levels had declined in the chronically stressed animals (RC) and in these animals LPS, but not restraint, was able to evoke an acute increase similar to intact animals.
Medial PVN levels of vasopressin mRNA did not vary significantly across any of the treatment conditions (P>0.05) (Fig. 4C ). However, it should be noted that control values for vasopressin mRNA values were variable and no clear pattern of responses was evident.
Discussion
These data show that chronic intermittent restraint stress leads to marked habituation of the corticosterone and CRH mRNA responses to the psychological stress of restraint (homotypic stressor), but causes no change in the corticosterone response and a marked cross-sensitization (facilitation) of the CRH mRNA response to the physical stress of LPS injection (heterotypic stressor). However, this pattern of response was largely unaffected by lesions of two areas implicated in the neural circuitry of responses to stress, the BST and PVT.
Effects of chronic stress on basal HPA and response to homotypic stress
As predicted from previous studies (7, 8, 29) , acute restraint of stress-naïve animals evokes both increased corticosterone (measured at 30 min) and increased CRH mRNA (measured at 4 h). Although not detected in all studies (2, 6, 8) , the present data also support the observation that chronic repetition of this restraint stress leads to a significant increase in basal corticosterone levels (15, 23) . In the present study, this effect was found to be greater when measured at the diurnal acrophase (18.00 h), and this possibly reflects the greater drive to the axis at this time in the cycle. However, despite this sustained increase in adrenocortical activity, the repeated restraint stress did not alter resting levels of CRH mRNA. This is consistent with other studies using 60-min periods of restraint (7, 8) , although longer periods of restraint (2 h) can evoke a significant tonic increase (20) . Nevertheless, the efficacy of the chronic intermittent restraint stress is further demonstrated by a decrease in body weight gain and an adrenal hypertrophy, which are similar to those reported using similar chronic stress (6, 20) .
In contrast to the increased basal levels, the very marked increase in circulating corticosterone seen following an acute restraint was significantly reduced as a result of daily repeated restraint stress. Although not as marked as reported in other studies, this habituation to the homotypic stress is consistent with reports that daily periods of prolonged restraint stress result in habituation of HPA activation (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The reasons for the smaller habituation may relate to the time point at which the sample was taken or the duration of the stress. For example, the present samples were obtained by tail nick immediately after the 30 min of restraint (when corticosterone levels would be peaking), while other studies have taken samples at the end of 1 h (9) or 2 h (4) of restraint, when adaptation to the acute stimulus may have occurred. Studies involving sampling throughout a period of restraint have shown that repetitive stress leads to a more rapid recovery (15) . We have previously shown that increasing the frequency of repeated periods of restraint stress (60 min daily for every 2, 3 or 7 days) causes a graded habituation of the corticosterone and CRH heteronuclear RNA and mRNA responses to acute restraint (7) . Furthermore, the degree of habituation of the corticosterone response appears to be a function of the intensity of the restraint, with significant habituation occurring with daily administration of 60 min (5-9) or 120 min (4) of restraint, but no habituation with only 10-15 min of restraint (3, 24) . The present data show that 30 min is sufficient to induce significant habituation.
In addition to the habituation of the corticosterone response, restraint-induced CRH mRNA was also affected by repeated restraint. Similar to previous observations (7, 8, 29) this habituation was absolute in that no increase in CRH mRNA was observed in the chronically stressed animals. This suggests that any afferent signal reaching the hypophysiotrophic neurones of the PVN is insufficient to activate the normal molecular reaction to stress. This reduced afferent activation is substantiated by the fact that levels of stressinduced c-fos mRNA or Fos protein are markedly attenuated in stress-habituated animals both in the PVN (5, 9, (30) (31) (32) (33) and in other regions of the neuroaxis (4, 5) .
In contrast to the acute increase and chronic habituation of CRH mRNA levels, vasopressin mRNA levels were unaltered by either stress. Former studies have shown that repeated daily restraint stress causes a significant increase in the number of CRH-and vasopressin-immunoreactive neurones in the medial parvocellular PVN (56) and an increase in vasopressin-immunoreactivity in the median eminence (57) . Chronic restraint also causes an increase in vasopressin mRNA (26) (27) (28) 58) , the magnitude of which is a function of the frequency with which the animals were restrained (7). However, in the present study, we could detect no increase either in steady state vasopressin mRNA levels or the response to stress, a difference which may relate to the less severe stress employed. However, it should be noted that analysis of film autoradiograms is less sensitive than the counting of silver grains which has been previously used for the analysis of the effect of repeated restraint (7, 8) . Thus, although increased vasopressin expression has been reported to contribute a greater part of HPA regulation during chronic stress (59, 60) and to play a role in cross-sensitization to a heterotypic stress, the lack of any detectable increase and variable response in the present study would argue against this being a mechanism underlying the current data.
Cross-sensitization to the heterotypic stressor Whilst numerous studies have reported the habituation of HPA responses to a homotypic stressor, less is known about the processes underlying the cross-sensitization (increased responsiveness) of HPA responses to a heterotypic stress. Daily restraint [either 2.5 h/day for 10 or 16 days (2) or 6 h/day for 4 or 5 weeks (61)] potentiates the adrenocorticotopic hormone (ACTH) response to ether vapour, although these two studies differed in whether there was an increase (61) or no effect (2) on corticosterone. Similarly, animals given 4 h exposure to cold (4-6 uC) for 7 (19) or 21 (18) consecutive days showed enhanced ACTH and corticosterone responses to acute restraint stress, and 3 or 7 days of continuous cold exposure augmented the ACTH and corticosterone response to the stress of i.p. injection of saline (62) . The corticosterone response to i.p. hypertonic saline was also potentiated at a single time point in animals subjected to chronic intermittent restraint (8) . However, cross-sensitization of neuroendocrine activity does not occur in all cases. For example, the ACTH and corticosterone responses to electrical tail shock have been shown to be either unaffected (20, 22) or even reduced (63) by prior exposure to repeated immobilization. The present data also show that while the corticosterone response to restraint was habituated, there was no change in the magnitude of the response to LPS (i.e. no parallel habituation, but also no cross-sensitization). This is not due to a ceiling effect as the magnitude of the LPS-induced secretion is much less than that of the restraint. Unfortunately, the tail samples employed did not allow the determination of ACTH, and it was not been possible to conclude whether higher levels of the axis would have been affected. Nevertheless, these data are consistent with an earlier study by Mekaouche et al. (64) showing that the ACTH and corticosterone responses to LPS (25 mg/kg i.v) were unaffected by 7 days of orthostatic restraint, although, in this study, the corticosterone response was slightly enhanced by more severe restraint in the antiorthostatic (head-down tilt) position.
Despite the lack of cross-sensitization of LPS-induced corticosterone secretion, the present data further extend the observation that chronic intermittent restraint stress potentiates the CRH mRNA response to a heterotypic stressor. We have previously shown that 14 days of 60-min restraint stress caused a cross-sensitization of the CRH mRNA response to i.p. hypertonic saline measured at 120 min (8) . To our knowledge, this is the first demonstration of the simultaneous habituation and cross-sensitization of the CRH mRNA response to homotypic and heterotypic stressors, and further demonstrates the selective responding of the PVN. The greater sensitivity of the mRNA measures compared to the corticosterone levels, may reflect the fact that the former effectively integrates the whole response while the latter is a single time point in a dynamic response. Alternatively, these data may indicate that activation of CRH mRNA in response to heterotypic stressors is accompanied by a less effective secretagogues response with respect to peptide release (i.e. decreased CRH and replacement or replacement with less effective vasopressin). Measures of secretagogue peptide levels were not performed, so it cannot be specified whether the dissociation between mRNA and corticosterone responses seen in response to the LPS challenge reflect differences in neuronal activity versus terminal secretagogue content, respectively.
The mechanisms underlying habituation and crosssensitization are unclear, but recently it has been shown that habituation of the corticosterone response to repeated restraint can be fully reversed by acute administration of mineralocorticoid receptor antagonists (10) . However, steroid feedback cannot account for the whole of the mechanism, since habituation of restraint-induced c-fos mRNA expression occurs in adrenalectomized rats (4) , and habituation of the CRH mRNA response to restraint is not blocked by adrenalectomy, although the magnitude of habituation varies with the level of corticosterone replacement (29) . This suggests that the high levels of corticosterone occurring as a result of the repeated stress in some way may be permissive for habituation. Since the mineralocorticoid receptor is not expressed in the PVN, it seems likely that this permissive effect occurs on afferent pathways. In this respect, anterograde tracing has shown that adrenalectomy reduces the density of inputs arising from the BST to the PVN (37). Therefore, it would be expected that the raised corticosteroid levels in the chronically stressed animals might increase this innervation. Since the BST input is believed to involve inhibitory GABA neurones (65) (66) (67) (68) (69) , the increased innervation might lead to the suppression of responsiveness seen during habituation.
Effects of BST and PVT lesions on habituation and cross-sensitization
The present data show that the patterns of habituation and cross-sensitization of stress responses are largely unaffected by lesions of the BST and PVT, and that these lesions do not block either the diurnal pattern of HPA activity or the ability of the animals to respond to acute stimuli. Microscopic analysis of the lesions showed they extended throughout the anterior regions of the PVT, and the whole of the lateral BST around the anterior limb of the anterior commissure. The marked loss in cellularity suggests that a large number of neurones will have been lost in these regions, so that the lack of any effect on habituation or cross-sensitization is unlikely to be due to ineffective lesions. Furthermore, the lesions were not without any effects. Most notably, the PVT lesions raised basal corticosterone at both time points in the circadian cycle to levels similar to those in the chronically restrained animals. This suggests that the lesion removed a tonic inhibition to the axis and occluded any further stress-induced increase. This might occur if the normal effect of repeated restraint is to suppress the tonic inhibition that allows the mechanisms driving basal secretion to be facilitated. Recent reports have shown that ibotenic acid lesions of the PVT blocked the homotypic adaptation of the corticosterone response to restraint stress following repeated restraint (50) . These effects were not seen in the present study; however, a difference between our study and that of Bhatnagar et al. (50) is that their lesions were made with ibotenic acid, were directed towards the medial/posterior division of the PVT, and animals may have been used sooner after lesioning. However, Bhatnagar and Dallman (19) have also shown that there were no increases in restraint-induced Fos expression in the medial and anterior PVT after chronic cold treatment, but there was in the posterior PVT, and it is possible that the area we targeted for our lesions is not involved in the crosssensitization phenomenon.
While not affecting corticosterone levels, lesions of the BST showed a strong tendency towards increased basal CRH mRNA levels that occluded any further increase in response to acute restraint stress. Furthermore, following repeated restraint stress, BST lesioned animals showed the greatest increase in nadir levels of CORT, and a marked flattening of the diurnal variation in levels. The resultant change in glucocorticoid negative-feedback may have been responsible for the marked decrease in basal CRH mRNA levels in these animals. It is unclear what is driving this hyperactivity as both CRH and vasopressin mRNA levels were reduced in BST lesioned animals undergoing repeated restraint. The lack of any significant effect of BST lesions on the HPA response to acute restraint is consistent with a previous report describing a lack of effect of ibotenic acid lesions of the BST on restraintinduced ACTH and corticosterone release (70) . However, these lesions did block both the ACTH and corticosterone responses to a conditioned stress (3 days of 10 min exposure to a grid-bottomed chamber with a single footshock applied at the end of the period, and a fourth exposure without shock). In addition, the BST is one area which shows enhanced Fos expression to a psychological stress (electrified prod) following an earlier exposure to inescapable shocks (71) , suggesting that it may be involved in the transduction of a crosssensitized pathways. The BST is a relay area for projections to the brain stem and hypothalamus (including PVN), particularly those arising from the amygdala and hippocampus, and is involved in both anxiety/fear responding and coping. Notably, the medial amygdala projects to the medial anterior BST and may be responsible for mediating the differential activation of the PVN following repeated restraint stress (5) . Anterograde tracing from the BST has shown that areas of the anterior BST around the anterior commissure contribute to the innervation of the PVN (37) . Further studies will be required to determine to what extent these pathways contribute to adaptive responses in the HPA axis.
